A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD

A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD

Juthaporn Cowan,1,2 Sunita Mulpuru,1,2 Sara J Abdallah,2 Anchal Chopra,3 Andrew Purssell,1 Michaeline McGuinty,1 Gonzalo G Alvarez,1,2 Antonio Giulivi,2,4 Vicente Corrales-Medina,1,2 Derek MacFadden,1,2 Loree Boyle,1 Delvina Hasimja,1 Kednapa Thavorn,2,5,6 Ranjeeta Mallick,2 Shawn D Aaron,1,2 D Will...

Full description

Bibliographic Details
Main Authors: Cowan J, Mulpuru S, Abdallah SJ, Chopra A, Purssell A, McGuinty M, Alvarez GG, Giulivi A, Corrales-Medina V, MacFadden D, Boyle L, Hasimja D, Thavorn K, Mallick R, Aaron SD, Cameron DW
Format: Article
Language:English
Published: Dove Medical Press 2021-12-01
Series:International Journal of COPD
Subjects:
recurrent aecopd
pilot rct
immunoglobulin treatment
ivig
Online Access:https://www.dovepress.com/a-randomized-double-blind-placebo-control-feasibility-trial-of-immunog-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/a-randomized-double-blind-placebo-control-feasibility-trial-of-immunog-peer-reviewed-fulltext-article-COPD

Similar Items